|
|
 |
|
Viewing report
|
|
|
|
Partnering in the Global Generics Industry 2008: A Guide to Companies
Espicom Business Intelligence Ltd, July 2008, Pages: 406
Introduction 1
Argentina 7
Osmotica Pharmaceutical 7
Background 7
Products 8
Contact Details 8
Australia 9
Australian Pharmaceutical Industries 9
Background 9
Financials 10
Major Developments 10
Contact Details 14
GenePharm Australasia 15
Background 15
Products 15
Financials 16
Major Developments 16
Contact Details 18
Hamilton Laboratories 19
Background 19
Products 19
Contact Details 19
Sigma Pharmaceuticals 20
Background 20
Products 20
Financials 21
Major Developments 21
Contact Details 26
Bangladesh 27
Beximco Pharmaceuticals 27
Background 27
Products 27
Financials 29
Major Developments 30
Contact Details 31
Brazil 32
Aché 32
Background 32
Products 32
Financials 33
Major Developments 33
Contact Details 33
Americano 34
Background 34
Products 34
Financials 34
Contact Details 35
Biolab 36
Background 36
Contact Details 36
Biosintética 37
Background 37
Products 37
Financials 38
Contact Details 38
Cimed 39
Background 39
Products 40
Financials 40
Contact Details 40
Cristália 41
Background 41
Products 42
Contact Details 43
EMS-Sigma 44
Background 44
Products 45
Contact Details 46
Eurofarma 47
Background 47
Financials 48
Contact Details 48
Libbs Farmacêutica 49
Background 49
Financials 49
Major Developments 49
Contact Details 49
Medley 50
Background 50
Products 51
Financials 51
Major Developments 52
Contact Details 52
Bulgaria 53
Sopharma 53
Background 53
Products 53
Financials 53
Contact Details 54
Unipharm 55
Background 55
Contact Details 55
Canada 56
Labopharm 56
Background 56
Products 56
Financials 57
Major Developments 58
Contact Details 62
Orbus Pharma 63
Background 63
Products 63
Financials 64
Major Developments 65
Contact Details 69
Pharmascience 70
Background 70
Products 70
Major Developments 70
Contact Details 70
Chile 71
Andrómaco 71
Background 71
Products 71
Financials 72
Major Developments 73
Contact Details 73
Bestpharma 74
Background 74
Products 74
Contact Details 74
Biosano 75
Background 75
Finances 75
Contact Details 75
Maver 76
Background 76
Contact Details 76
Mintlab 77
Background 77
Contact Details 77
China 78
China Pharma Holdings 78
Background 78
Products 78
Financials 78
Contact Details 78
Colombia 79
Ecar 79
Background 79
Contact details 79
Genfar 80
Background 80
Contact Details 80
La Santé 81
Background 81
Contact Details 82
Lafrancol 83
Background 83
Contact Details 83
Costa Rica 84
Laboratorios Stein 84
Background 84
Contact Details 84
Croatia 85
Belupo 85
Background 85
Products 85
Contact Details 86
Denmark 87
Alternova 87
Background 87
Products 87
Contact Details 87
Copyfarm 88
Background 88
Products 88
Contact Details 88
Egypt 89
EIPICo 89
Background 89
Contact Details 89
France 90
Biogaran 90
Background 90
Contact Details 90
India 91
Alembic 91
Background 91
Products 91
Financials 92
Major Developments 93
Contact Details 93
Alkem Laboratories 94
Background 94
Products 94
Major Developments 94
Contact Details 95
Aurobindo Pharma 96
Background 96
Products 96
Financials 98
Major Developments 99
Contact Details 103
Biocon 104
Background 104
Products 104
Financials 105
Major Developments 106
Contact Details 107
Emcure Pharmaceuticals 108
Background 108
Major Developments 108
Contact Details 109
Gland Pharma 110
Background 110
Products 110
Contact Details 110
Glenmark Pharmaceuticals 111
Background 111
Products 111
Financials 112
Major Developments 113
Contact Details 119
Hetero Drugs 120
Background 120
Products 120
Contact Details 120
JB Chemicals & Pharmaceuticals 121
Background 121
Products 121
Financials 121
Major Developments 122
Contact Details 124
Jubilant Organosys 125
Background 125
Products 125
Financials 126
Major Developments 126
Contact Details 127
Lupin Laboratories 128
Background 128
Products 128
Financials 129
Major Developments 130
Contact Details 133
Natco Pharma 134
Background 134
Products 134
Financials 134
Major Developments 135
Contact Details 136
Orchid Chemicals & Pharmaceuticals 137
Background 137
Products 137
Financials 138
Major Developments 139
Contact Details 143
Strides Arcolab 144
Background 144
Products 144
Financials 144
Major Developments 145
Contact Details 152
Sun Pharmaceutical Industries 153
Background 153
Products 153
Financials 154
Major Developments 155
Contact Details 159
Torrent Pharmaceuticals 160
Background 160
Products 160
Financials 160
Major Developments 161
Contact Details 162
Indonesia 163
Kimia 163
Background 163
Contact Details 163
Ireland 164
Consilient Health 164
Background 164
Products 164
Contact Details 166
GeneMedix 167
Background 167
Products 167
Financials 167
Major Developments 168
Contact Details 172
Israel 173
Dexcel 173
Background 173
Products 173
Major Developments 174
Contact Details 174
Taro Pharmaceutical Industries 175
Background 175
Products 176
Financials 178
Major Developments 180
Contact Details 182
Italy 183
Eurand 183
Background 183
Products 183
Contact Details 183
Japan 185
Nichi-iko Pharmaceutical 185
Background 185
Major Developments 185
Contact Details 186
Towa Pharmaceutical 187
Background 187
Financials 187
Major Developments 188
Contact Details 189
Jordan 190
Hikma 190
Background 190
Products 190
Financials 193
Major Developments 196
Contact Details 198
Kenya 199
Regal Pharmaceuticals 199
Background 199
Products 199
Major Developments 199
Contact Details 199
Latvia 200
Grindeks 200
Background 200
Products 200
Financials 201
Major Developments 202
Contact Details 205
Lithuania 206
Sanitas 206
Background 206
Products 206
Financials 206
Major Developments 208
Contact Details 208
Malaysia 209
Inno Biologics 209
Background 209
Products 209
Contact Details 210
Mexico 211
Laboratorios Kendrick 211
Background 211
Contact Details 211
Laboratorios Silanes 212
Background 212
Contact Details 212
Pakistan 213
CCL 213
Background 213
Contact Details 213
Dr Raza Pharma 214
Background 214
Contact Details 214
Epla Labs 215
Background 215
Contact Details 215
Highnoon Laboratories 216
Background 216
Products 216
Financials 216
Contact Details 216
Peru 217
Farmindustria 217
Background 217
Contact Details 217
Infarmasa 218
Background 218
Financials 219
Contact Details 219
Portugal 220
Hovione FarmaCiencia 220
Background 220
Products 220
Financials 221
Major Developments 221
Contact Details 223
Romania 224
Antibiotice 224
Background 224
Products 224
Contact Details 225
Europharm 226
Background 226
Contact Details 226
Russia 227
Akrikhin 227
Background 227
Products 227
Contact Details 228
Bryntsalov A 229
Background 229
Erka Farm 230
Background 230
Farmacon 231
Background 231
Contact Details 231
Veropharm 232
Background 232
Contact Details 232
Saudi Arabia 233
Tabuk Pharmaceutical Manufacturing 233
Background 233
Contact Details 233
Slovakia 234
Biotika 234
Background 234
Financials 234
Contact Details 234
South Africa 235
Adcock Ingram 235
Background 235
Products 236
Major Developments 237
Contact Details 238
Enaleni Pharmaceuticals 239
Background 239
Products 239
Financials 240
Major Developments 240
Contact Details 242
Spain 243
Combino Pharm 243
Background 243
Products 243
Major Developments 243
Contact Details 244
Invent Farma Group 245
Background 245
Products 245
Major Developments 245
Contact Details 246
Laboratorios Cinfa 247
Background 247
Products 247
Financials 247
Major Developments 247
Contact Details 247
Switzerland 248
Azad 248
Background 248
Products 248
Major Developments 249
Contact Details 249
Mepha Pharma 250
Background 250
Contact Details 250
Spirig 251
Background 251
Products 251
Contact Details 251
Streuli 252
Background 252
Contact Details 252
Turkey 253
Abdi Ibrahim 253
Background 253
Products 253
Major Developments 254
Contact Details 254
Bilim Pharmaceuticals 255
Background 255
Products 255
Contact Details 255
Mustafa Nevzat Pharmaceuticals 256
Background 256
Products 256
Major Developments 256
Contact Details 257
UK 258
Goldshield Group 258
Background 258
Products 258
Financials 259
Major Developments 260
Contact Details 262
Kent Pharmaceuticals 263
Background 263
Major Developments 263
Contact Details 264
ProStrakan 265
Background 265
Products 266
Financials 266
Major Developments 268
Contact Details 270
Rosemont Pharmaceutical 271
Background 271
Products 271
Major Developments 271
Contact Details 272
USA 273
APP Pharmaceuticals 273
Background 273
Products 273
Financials 275
Major Developments 276
Contact Details 276
Akorn 277
Background 277
Products 277
Financials 278
Major Developments 279
Contact Details 281
Amneal Pharmaceuticals 282
Background 282
Products 282
Major Developments 284
Contact Details 284
Amphastar Pharmaceuticals 285
Background 285
Products 285
Major Developments 286
Contact Details 287
Anchen Pharmaceuticals 288
Background 288
Products 288
Major Developments 289
Contact Details 290
Banner Pharmacaps 291
Background 291
Products 291
Major Developments 291
Contact Details 292
Bedford Laboratories 293
Background 293
Products 293
Financials 295
Major Developments 295
Contact Details 295
Bio-Nucleonics 296
Background 296
Products 296
Contact Details 296
Boca Pharmacal 297
Background 297
Products 297
Contact Details 297
Caraco Pharmaceutical Laboratories 298
Background 298
Products 298
Financials 299
Major Developments 300
Contact Details 301
Carolina Medical Products Company 302
Background 302
Products 302
Contact Details 302
Cedar Pharmaceuticals 303
Background 303
Products 303
Contact Details 303
Cedarburg Pharmaceuticals 304
Background 304
Products 304
Contact Details 304
Cephazone Pharma 305
Background 305
Products 305
Contact Details 305
CorePharma 306
Background 306
Products 306
Major Developments 307
Contact Details 307
Cypress Pharmaceutical 308
Background 308
Products 308
Major Developments 308
Contact Details 309
Ferndale Laboratories 310
Background 310
Products 310
Major Developments 310
Contact Details 310
Fleming Pharmaceuticals 311
Background 311
Products 311
Contact Details 311
Fougera 312
Background 312
Products 312
Major Developments 313
Contact Details 313
G&W Laboratories 314
Background 314
Products 314
Contact Details 314
GeneraMedix 315
Background 315
Products 315
Major Developments 315
Contact Details 315
Glades Pharmaceuticals 317
Background 317
Products 317
Major Developments 317
Contact Details 317
GC Hanford Manufacturing 318
Background 318
Products 318
Contact Details 318
Harmony Labs 319
Background 319
Products 319
Contact Details 319
Heritage Pharmaceuticals 320
Background 320
Products 320
Major Developments 320
Contact Details 321
Hi-Tech Pharmacal 322
Background 322
Products 322
Financials 323
Major Developments 323
Contact Details 325
Impax Laboratories 326
Background 326
Products 326
Financials 327
Major Developments 329
Contact Details 336
Indicus Pharmaceuticals 337
Background 337
Products 337
Contact Details 337
InvaGen Pharmaceuticals 338
Background 338
Products 338
Major Developments 338
Contact Details 340
Kremers Urban Development Company (KUDCo) 341
Background 341
Products 341
Major Developments 342
Contact Details 342
KVK-Tech 343
Background 343
Products 343
Contact Details 343
KV Pharmaceutical 344
Background 344
Products 344
Financials 345
Major Developments 346
Contact Details 349
Luitpold Pharmaceuticals 350
Background 350
Products 350
Major Developments 351
Contact Details 352
Lyne Laboratories 353
Background 353
Products 353
Contact Details 353
Mallinckrodt 354
Background 354
Products 354
Major Developments 355
Contact Details 355
Mikart 356
Background 356
Products 356
Contact Details 356
Neil Laboratories 357
Background 357
Products 357
Contact Details 357
Nephron Pharmaceuticals 358
Background 358
Products 358
Contact Details 358
Paddock Laboratories 359
Background 359
Products 359
Major Developments 360
Contact Details 360
Parenta Pharmaceuticals 361
Background 361
Products 361
Major Developments 361
Contact Details 362
Pharmaceutical Associates 363
Background 363
Products 363
Contact Details 363
PharmaForce 364
Background 364
Products 364
Contact Details 365
Prasco 366
Background 366
Products 366
Contact Details 366
Prometheus Laboratories 367
Background 367
Products 367
Contact Details 367
Roxane Laboratories 368
Background 368
Products 368
Financials 369
Major Developments 370
Contact Details 371
RxElite 372
Background 372
Products 372
Financials 372
Contact Details 372
Silarx Pharmaceuticals 373
Background 373
Products 373
Contact Details 373
Spear Pharmaceuticals 374
Background 374
Products 374
Major Developments 374
Contact Details 375
Spectrum Pharmaceuticals 376
Background 376
Products 376
Financials 376
Major Developments 377
Contact Details 380
Stiefel 381
Background 381
Products 381
Major Developments 381
Contact Details 381
SuperGen 382
Background 382
Products 382
Financials 382
Contact Details 382
Three Rivers Pharmaceuticals 383
Background 383
Products 383
Major Developments 383
Contact Details 385
URL Pharma 386
Background 386
Products 386
Contact Details 391
Upsher-Smith Laboratories 392
Background 392
Products 392
Major Developments 392
Contact Details 396
Vista Pharmaceuticals 397
Background 397
Products 397
Contact Details 397
VistaPharm 398
Background 398
Products 398
Contact Details 398
X-GEN Pharmaceuticals 399
Background 399
Products 399
Major Developments 399
Contact Details 400
Venezuela 401
Calox Internacional 401
Background 401
Contact Details 401
Cofasa 402
Background 402
Contact Details 402
Elter (Galeno Química) 403
Background 403
Contact Details 403
Kimiceg 404
Background 404
Contact Details 404
Leti 405
Background 405
Contact Details 405
Meyer 406
Background 406
Contact Details 406
Companies in the report by country of origin 2
Osmotica Pharmaceutical ANDA Approvals, 2002-08 8
Beximco Pharmaceuticals: 2002 – 2007 Results (BDT millions) 29
Aché: Gross Revenues by Therapeutic Area, 2006 33
Biosintética: Pharmaceutical Sales, 2001 - 2004 38
Biosintética: Pharmaceutical Sales by Therapeutic Category, 2004 38
Cimed: Sales, 2004 - 2007 40
Cristálias Business Units, 2006 41
Cristálias International Representatives, 2006 42
EMS Generics Registrations & Marketing Authorisations by Division, 2006 45
Eurofarma: Pharmaceutical & Generic Sales, 2004 - 2007 48
Libbs: Pharmaceutical Sales, 2000 - 2006 49
Medleys International Agreements, 1992 - 2005 50
Medley: Sales, 2006 - 2007 51
Sopharma: Financial Data, 1999 – 2006 (Leva 000s) 53
Labopharm: Financial Results, 2004 – 2007 (C$000s) 57
Orbus: Financial Results, 2003 – 2007 (C$000s) 64
Orbus: Financial Results by Geography, 2006 – 2007 (C$000s) 64
Andrómaco: Financial Results, 2000 - 2005 72
Alembic: Financial Results, 2003 – 2007 (Rs millions) 92
Aurobindo Pharma ANDA Approvals, 2002-08 96
Aurobindo Pharma: Financial Results, 2003 - 2007 99
Biocon: Financial Results, 2003 - 2007 105
Gland Pharma ANDA Approvals, 2002-08 110
Glenmark Pharmaceuticals ANDA Approvals, 2002-08 111
Glenmark Pharmaceuticals: FY2007-08 results (Rs millions) 112
Glenmark Pharmaceuticals: FY2007-08 sales breakdown (Rs millions) 112
Unique Pharmaceutical Laboratories ANDA Approvals, 2002-08 121
JB Chemicals & Pharmaceuticals: Financial Results, FY2004-5 – FY2007-8 (Rs millions)122
Trigen Laboratories / Jubilant Pharmaceuticals ANDA Approvals, 2002-08 125
Jubilant Organosys: Financial Results, FY2001 – FY2007 (Rs millions) 126
Lupin Laboratories ANDA Approvals, 2002-08 129
Lupin Laboratories: Financial Results, FY2001 – 2008 (US$000s) 130
Natco Pharma ANDA Approvals, 2002-08 134
Natco Pharma: Financial Results, 2004 – 2007 (Rs millions) 135
Orchid Healthcare ANDA Approvals, 2002-08 138
Orchid Chemicals & Pharmaceuticals: FY2004-5 – FY2007-8 results (Rs millions) 139
Akorn-Strides ANDA Approvals, 2002-08 144
Strides Arcolab: Financial Results, 2004 – 2007 (Rs millions) 144
Sun Pharmaceutical Laboratories ANDA Approvals, 2002-08 154
Sun Pharmaceutical Industries: Financial Results, 2005 – 2008 (Rs millions) 154
Torrent Pharmaceuticals ANDA Approvals, 2002-08 160
Torrent Pharmaceuticals: Financial Results, 2007 – 2008 (Rs millions) 161
GeneMedix: 2007 Results 167
Dexcel ANDA Approvals, 2002-08 173
Taro Pharmaceutical Industries ANDA Approvals, 2002-08 177
Taro Pharmaceutical Industries: Financial Results, 2000 – 2005 (US$000s) 178
Taro Pharmaceutical Industries: Sales by Location, 2002 – 2005 (US$000s) 179
Eurand ANDA Approvals, 2002-08 183
Towa Pharmaceutical: Financial Results, FY2004 – FY2007 (¥ millions) 187
Hikma: 2007 filings 191
Hikma Pharmaceuticals ANDA Approvals, 2002-08 192
West-Ward ANDA Approvals, 2002-08 193
Hikma: 2007 Results (US$ millions) 194
Hikma: 2007 Results by Region (US$ millions) 194
Grindeks Group: Financial Results, 2004 – 2007 (LVL000s) 201
Grindeks Group: Sales by Location, 2004 – 2007 (LVL000s) 202
Sanitas: Financial Results, 2002 – 2007 (LTL000s) 207
Sanitas: Selected Financial Results by Region, 2004 – 2007 (LTL000s) 207
Goldshield: Financial Results, 2003 – 2007 (£000s) 259
Goldshield: Sales by Region, 2006 – 2007 (£000s) 259
Goldshield: Selected Sales by Segment, 2006 – 2007 (£000s) 260
ProStrakan: Financial Results, 2002 – 2007 (£000s) 266
ProStrakan: Selected Financial Results by Destination, 2002 – 2007 (£000s) 267
American Pharmaceutical Partners ANDA Approvals, 2002-06 274
Abraxis ANDA Approvals, 2006-08 274
APP Pharmaceuticals ANDA Approvals, 2008 275
APP Pharmaceuticals: 2007 results (US$ millions) 275
Akorn ANDA Approvals, 2002-08 277
Akorn-Strides ANDA Approvals, 2002-08 277
Akorn: Financial Results, 2001 – 2007 (US$000s) 278
Amneal Pharmaceuticals ANDA Approvals, 2006-08 283
Akyma Pharmaceuticals ANDA Approvals, 2002-08 283
Interpharm ANDA Approvals, 2002-08 283
Amphastar Pharmaceuticals ANDA Approvals, 2002-08 285
International Medication Systems ANDA Approvals, 2002-08 285
Anchen Pharmaceuticals ANDA Approvals, 2002-08 288
Banner Pharmacaps ANDA Approvals, 2002-08 291
Bedford Laboratories ANDA Approvals, 2002-08 293
Ben Venue Laboratories ANDA Approvals, 2002-08 295
Bio-Nucleonics ANDA Approvals, 2002-08 296
Boca Pharmacal ANDA Approvals, 2002-08 297
Caraco Pharmaceutical Laboratories ANDA Approvals, 2002-08 299
Caraco Pharmaceutical Laboratories: Financial Results, FY2005 – FY2008 (US$000s) 300
Carolina Medical Products ANDA Approvals, 2002-08 302
Cedar Pharmaceuticals ANDA Approvals, 2002-08 303
Cephazone Pharma ANDA Approvals, 2002-08 305
CorePharma ANDA Approvals, 2002-08 306
Cypress Pharmaceutical ANDA Approvals, 2002-08 308
Ferndale Laboratories ANDA Approvals, 2002-08 310
Fleming & Company Pharmaceuticals ANDA Approvals, 2002-08 311
Altana ANDA Approvals, 2002-08 312
G&W Laboratories ANDA Approvals, 2002-08 314
GeneraMedix ANDA Approvals, 2002-08 315
Glades Pharmaceuticals ANDA Approvals, 2002-08 317
GC Hanford Manufacturing ANDA Approvals, 2002-08 318
Harmony Labs ANDA Approvals, 2002-08 319
Hi-Tech Pharmacal ANDA Approvals, 2002-08 322
Hi-Tech Pharmacal: FY2005 – FY2007 Results (US$ millions) 323
Impax Laboratories ANDA Approvals, 2002-08 327
Impax Laboratories: Financial Results, 1999 – 2003 (US$000s) 328
Indicus Pharmaceuticals ANDA Approvals, 2002-08 337
InvaGen Pharmaceuticals ANDA Approvals, 2002-08 338
KUDCo ANDA Approvals, 2002-08 341
KVK-Tech ANDA Approvals, 2002-08 343
KV Pharmaceuticals / Ethex ANDA Approvals, 2002-08 344
KV Pharmaceutical: Financial Results, 2002 – 2008 (US$ millions) 345
Luitpold Pharmaceuticals ANDA Approvals, 2002-08 351
Lyne Laboratories ANDA Approvals, 2002-08 353
Mallinckrodt ANDA Approvals, 2002-08 354
Mikart ANDA Approvals, 2002-08 356
Neil Laboratories ANDA Approvals, 2002-08 357
Nephron Pharmaceuticals ANDA Approvals, 2002-08 358
Paddock Laboratories ANDA Approvals, 2002-08 359
Parenta Pharmaceuticals ANDA Approvals, 2002-08 361
Pharmaceutical Associates ANDA Approvals, 2002-08 363
PharmaForce ANDA Approvals, 2002-08 364
Prometheus Laboratories ANDA Approvals, 2002-08 367
Roxane Laboratories ANDA Approvals, 2002-08 369
RxElite ANDA Approvals, 2002-08 372
Silarx Pharmaceuticals ANDA Approvals, 2002-08 373
Spear Pharmaceuticals ANDA Approvals, 2002-08 374
Spectrum Pharmaceuticals ANDA Approvals, 2002-08 376
Spectrum Pharmaceuticals: Financial Results, 2001 – 2007 (US$000s) 376
Stiefel ANDA Approvals, 2002-09 381
SuperGen ANDA Approvals, 2002-08 382
Three Rivers ANDA Approvals, 2002-08 383
Mutual Pharmaceutical Company ANDA Approvals, 2002-08 387
Upsher-Smith Laboratories ANDA Approvals, 2002-08 392
Vista Pharmaceuticals ANDA Approvals, 2002-08 397
VistaPharm ANDA Approvals, 2002-08 398
X-Gen Pharmaceuticals ANDA Approvals, 2002-08 399
Customers who bought this item also bought
Partnering in the Global Generics Industry 2009: A Guide to Companies
Pharmaceuticals - Global Outlook
Emerging Generic Drug Companies Worldwide 2007
RFID for Healthcare and Pharmaceuticals 2009-2019
RFID for Healthcare and Pharmaceuticals 2008-2018
M356 ANDA Review Call - Momenta Pharmaceuticals, Inc., - Earnings Transcript
Dairy Products - Global Outlook
Contact Lenses and Solutions - Global Strategic Business Report
Watson Pharmaceuticals Generics Company Intelligence Report
Pharmaceuticals - Global Outlook 2006
Pharmaceuticals: Global Industry Guide
Contact Lenses and Solutions - A Global Market Review
|
|
|
|
